October 31, 2017Share
August 16, 2017Share
Biofrontera mulls US IPO to fund skin cancer drug
June 20, 2017Share
US biotech looks to bolster pipeline.
Clovis looks for new drugs after Rubraca success
May 5, 2017Share
BioHaven raises $168 million with biggest biotech IPO seen this year.
Biotech IPO market heats up as BioHaven’s debut impresses
April 19, 2017Share
Are biotech IPOs back in fashion?
March 13, 2017Share
Tocagen aims for IPO to fund brain cancer trial
January 4, 2017Share
Massachusetts-based company will test the waters for biotech sector
Jounce set to make first biotech IPO of 2017
September 12, 2016Share
CRISPR Therapeutics plans Nasdaq launch
April 27, 2016Share
Never mind the chill, biotech IPO winter will pass